Connect Portal

  • Clinical Testing
    • OmniSeq INSIGHT
    • Order Test
    • Specimen Requirements
  • BioPharma Services
  • Publications
  • Patient Support
  • About
    • About
    • Leadership
    • News
    • Careers
    • Forms
    • Contact
Oncologist uptake of comprehensive genomic profile guided targeted therapy

Oncologist uptake of comprehensive genomic profile guided targeted therapy

by Christina Black | Jul 23, 2019

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing

by OmniSeq Staff | Jan 18, 2019

Follow Us on Twitter

OmniSeq Follow

Finding the right drug or the right trial...for every #cancer patient. #immunotherapy Pronounced OmniSeek

Avatar
Avatar OmniSeq @omniseq ·
3 Jun

LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine

Reply on Twitter 1532751537994342401 Retweet on Twitter 1532751537994342401 Like on Twitter 1532751537994342401 5 Twitter 1532751537994342401
Avatar OmniSeq @omniseq ·
27 May

June 3-7 | Chicago, I Join us @ASCO 2022. LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers.
#2561-Developmental Therapeutics—Immunotherapy
Sunday, June 5, 8-11:00 AM CDT

Reply on Twitter 1530217104867196928 Retweet on Twitter 1530217104867196928 Like on Twitter 1530217104867196928 3 Twitter 1530217104867196928
Avatar OmniSeq @omniseq ·
27 May

June 3-7 | Chicago, IL Join us at the @ASCO 2022. Comprehensive transcriptomic analysis of immune checkpoint markers in a pan-cancer cohort: Implications for response and resistance.
#376244-Developmental Therapeutics—Immunotherapy Sunday, June 5, 2022, 8:00 AM -11:00 AM CDT

Reply on Twitter 1530216482998734850 Retweet on Twitter 1530216482998734850 Like on Twitter 1530216482998734850 3 Twitter 1530216482998734850
Avatar OmniSeq @omniseq ·
27 May

June 3-7 | Chicago, IL Join us at the 2022 ASCO Annual Meeting.
Comprehensive genomic and immune profiling defines immunotherapy treatment in NSCLC patients with low PD-L1 IHC.
#2623 -Developmental Therapeutics—Immunotherapy
Sunday, June 5, 2022, 8:00 AM -11:00 AM CDT

Reply on Twitter 1530215721862680578 Retweet on Twitter 1530215721862680578 Like on Twitter 1530215721862680578 1 Twitter 1530215721862680578
Avatar OmniSeq @omniseq ·
5 May

Last year, the Buffalo-based cancer diagnostics firm @OmniSeq quietly was acquired by one of the world's largest life science companies, @Labcorp . Developing molecular diagnostic tests for cancer patients, OmniSeq is looking to scale its operations.
https://tinyurl.com/muxryphz

Reply on Twitter 1522266608911142917 Retweet on Twitter 1522266608911142917 Like on Twitter 1522266608911142917 6 Twitter 1522266608911142917
Load More...

  • Facebook
  • Twitter
©2022 OmniSeq Corporation | Privacy Practices and Terms of Use. Regulatory   .